Genmab
GMAB
$31.55
Share price
0.47%
Change (1 day)
-30.02%
Change (1 year)
Categories
Revenue for Genmab (GMAB)
Revenue in 2024 (TTM): A$4.72 Billion
According to Genmab's latest financial reports the company's current revenue (TTM 
) is A$4.85 Billion. an increase over the revenue in the year 2023 that were of A$3.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genmab from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$4.99 B | 42.71% |
| 2023 | A$3.49 B | 15.87% |
| 2022 | A$3.01 B | 65.36% |
| 2021 | A$1.82 B | -10.23% |
| 2020 | A$2.03 B | 77.34% |
| 2019 | A$1.14 B | 70.15% |
| 2018 | A$0.67 B | 42.08% |
| 2017 | A$0.47 B | 29.05% |
| 2016 | A$0.36 B | 59.67% |
| 2015 | A$0.23 B | 27.08% |
| 2014 | A$0.18 B | 36.24% |
| 2013 | A$0.13 B | 63.15% |
| 2012 | A$81.51 M | 28.91% |
| 2011 | A$63.23 M | -37.47% |
| 2010 | A$0.10 B | -16.8% |
| 2009 | A$0.12 B |